Overview

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Status:
Completed
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Alexandria University
Treatments:
Epoetin Alfa